Different single nucleotide polymorphisms (SNPs) have been shown to weaken ascorbate transport and to reduce plasma levels with a trend toward a higher cancer risk for SLC23A1 variants [111,174,175,176,177]. This evidence concerns the gene SLC23A1 and cancer.